121 related articles for article (PubMed ID: 11991582)
1. Analysis of local recurrence in patients with selected T1-3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy-alone regimen for cure.
Laccourreye O; Veivers D; Bassot V; Ménard M; Brasnu D; Laccourreye H
Ann Otol Rhinol Laryngol; 2002 Apr; 111(4):315-21; discussion 321-2. PubMed ID: 11991582
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders.
Laccourreye O; Veivers D; Hans S; Ménard M; Brasnu D; Laccourreye H
Cancer; 2001 Sep; 92(6):1504-11. PubMed ID: 11745228
[TBL] [Abstract][Full Text] [Related]
4. Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience.
Brumund KT; Gutierrez-Fonseca R; Garcia D; Babin E; Hans S; Laccourreye O
Ann Otol Rhinol Laryngol; 2005 Apr; 114(4):314-22. PubMed ID: 15895788
[TBL] [Abstract][Full Text] [Related]
5. [Exclusive chemotherapy in T1-T3N0 cancers of the vocal cord with complete clinical response after neoadjuvant treatment with a cisplatin-fluorouracil combination].
Laccourreye O; Bassot V; Brasnu D; Jouffre V; Ménard M; Laccourreye H
Presse Med; 1995 Oct; 24(29):1337-40. PubMed ID: 7494844
[TBL] [Abstract][Full Text] [Related]
6. Analysis of local recurrence in patients with selected T1-3N0M0 squamous cell carcinoma of the true vocal cord managed with platinum-based chemotherapy--alone regimen for cure.
Weymuller EA
Ann Otol Rhinol Laryngol; 2002 Sep; 111(9):860. PubMed ID: 12296346
[No Abstract] [Full Text] [Related]
7. Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx.
Holsinger FC; Lin HY; Bassot V; Laccourreye O
Cancer; 2009 Sep; 115(17):3909-18. PubMed ID: 19551883
[TBL] [Abstract][Full Text] [Related]
8. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients.
Chevalier D; Laccourreye O; Brasnu D; Laccourreye H; Piquet JJ
Ann Otol Rhinol Laryngol; 1997 May; 106(5):364-9. PubMed ID: 9153099
[TBL] [Abstract][Full Text] [Related]
9. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.
Laccourreye O; Weinstein G; Brasnu D; Bassot V; Cauchois R; Jouffre V; Garcia D; Laccourreye H
Cancer; 1994 Nov; 74(10):2781-90. PubMed ID: 7954237
[TBL] [Abstract][Full Text] [Related]
10. Metachronous second primary cancers after successful partial laryngectomy for invasive squamous cell carcinoma of the true vocal cord.
Laccourreye O; Veivers FD; Hans S; Brasnu FD; Garcia D; Laccourreye FL
Ann Otol Rhinol Laryngol; 2002 Mar; 111(3 Pt 1):204-9. PubMed ID: 11913679
[TBL] [Abstract][Full Text] [Related]
11. Vertical partial laryngectomy versus supracricoid partial laryngectomy for selected carcinomas of the true vocal cord classified as T2N0.
Laccourreye O; Laccourreye L; Garcia D; Gutierrez-Fonseca R; Brasnu D; Weinstein G
Ann Otol Rhinol Laryngol; 2000 Oct; 109(10 Pt 1):965-71. PubMed ID: 11051438
[TBL] [Abstract][Full Text] [Related]
12. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
[TBL] [Abstract][Full Text] [Related]
13. A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis.
Laccourreye O; Diaz EM; Bassot V; Muscatello L; Garcia D; Brasnu D
Cancer; 1999 Jan; 85(1):40-6. PubMed ID: 9921972
[TBL] [Abstract][Full Text] [Related]
14. [Long term results of exclusive chemotherapy for glottic squamous cell carcinoma complete clinical responders after induction chemotherapy].
Vachin F; Hans S; Atlan D; Brasnu D; Menard M; Laccourreye O
Ann Otolaryngol Chir Cervicofac; 2004 Jun; 121(3):140-7. PubMed ID: 15223999
[TBL] [Abstract][Full Text] [Related]
15. [Cisplatin-fluorouracil chemotherapy in epidermoid cancers of glottic origin staged as T2].
Laccourreye O; Bassot V; Naudo P; Jouffre V; Brasnu D; Laccourreye H
Ann Otolaryngol Chir Cervicofac; 1994; 111(5):281-91. PubMed ID: 7755306
[TBL] [Abstract][Full Text] [Related]
16. Value and limits of non-robotic transoral oropharyngectomy for local control of T1-2 invasive squamous cell carcinoma of the tonsillar fossa.
Laccourreye O; Malinvaud D; Holostenco V; Ménard M; Garcia D; Bonfils P
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):141-6. PubMed ID: 25846120
[TBL] [Abstract][Full Text] [Related]
17. Local recurrence after vertical partial laryngectomy, a conservative modality of treatment for patients with Stage I-II squamous cell carcinoma of the glottis.
Laccourreye O; Gutierrez-Fonseca R; Garcia D; Hans S; Hacquart N; Ménard M; Brasnu D
Cancer; 1999 Jun; 85(12):2549-56. PubMed ID: 10375101
[TBL] [Abstract][Full Text] [Related]
18. ["Limited" cancers of the glottic stage of the larynx and exclusive chemotherapy--15 years of experience].
Laccourreye H
Bull Acad Natl Med; 1997 Apr; 181(4):641-8; discussion 648-9. PubMed ID: 9312344
[TBL] [Abstract][Full Text] [Related]
19. Laryngofissure and cordectomy for glottic carcinoma limited to the mid third of the mobile true vocal cord.
Muscatello L; Laccourreye O; Biacabe B; Hans S; Ménard M; Brasnu D
Laryngoscope; 1997 Nov; 107(11 Pt 1):1507-10. PubMed ID: 9369398
[TBL] [Abstract][Full Text] [Related]
20. Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus. Part II: Incidence and consequences of local recurrence.
Kania R; Hans S; Garcia D; Brasnu D; De Mones E; Laccourreye O
Ann Otol Rhinol Laryngol; 2005 Feb; 114(2):95-104. PubMed ID: 15757187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
